Omalizumab as a therapeutic alternative for chronic urticaria.
Callejas-Rubio
José Luis
JL
Sánchez-Cano
Daniel
D
Lara
Maria Angeles
MA
Ortego-Centeno
Norberto
N
D000328:Adult; D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D005260:Female; D006801:Humans; D008875:Middle Aged; D000069444:Omalizumab; D014581:Urticaria / Q000188:drug therapy*
D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab